UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records

Table 4 2014 prevalence^a of pregnancy and underlying health conditions among women aged 11–49 years, N = 1,181,840

	Scotland N = 205,542		Northern Ireland N = 55,559		Wales N = 177,412		England N = 743,327
Among all women aged 11–49 years	n	Point prevalence /100,000 (95% CI)	n	Point prevalence /100,000 (95% CI)	n	Point prevalence /100,000 (95% CI)	n	Point prevalence /100,000 (95% CI)
Pregnant or any underlying health condition^b	34,051	16,566 (16,406–16,728)	9234	16,620 (16,311–16,932)	31,140	17,552 (17,376–17,730)	117,680	15,832 (15,749–15,915)
Any underlying health condition^b	31,389	15,271 (15,116–15,428)	8317	14,970 (14,674–15,269)	28,733	16,196 (16,024–16,368)	102,121	13,738 (13,660–13,817)
Pregnant	3067	1492 (1440–1545)	1069	1924 (1811–2042)	2834	1597 (1540–1657)	17,755	2389 (2354–2424)
Prevalence of underlying health conditions, ^b stratified by pregnancy status, among women aged 11–49 years
Pregnant with an underlying health condition^b	405	13,205 (12,026–14,455)	152	14,219 (12,179–16,458)	427	15,067 (13,769–16,458)	2196	12,368 (11,887–12,862)
Not pregnant, with an underlying health condition^b	30,984	15,303 (15,146–15,460)	8165	14,984 (14,686–15,287)	28,306	16,214 (16,041–16,388)	99,925	13,772 (13,693–13,851)

95% CI 95% confidence interval.
^a Point prevalence on 5 March 2014.
^b Underlying health conditions comprised: any history of chronic respiratory disease other than asthma, heart disease, kidney disease, neurological conditions such as multiple sclerosis, diabetes mellitus; or current asthma, severe obesity, or immunosuppression; assessed at each index date.

ISSN: 1471-2458